You can BS and gaslight as much as you want about Flaskworks but there may be quite a few folks who are waiting for UK approval pump to get out or exit a significant portion of their investment. These folks are not going to wait for Flaskworks. It would be stupid to hold on if a big pharma partner is not revealed at UK approval.
Without non dilutive cash injection, this will take 3-4 years before we get any traction. This management is not capable of building shareholder value over an extended duration, so why would you not sell if and when the opportunity presents itself at the UK approval.
Flaskworks may be another 18 months at the very least before it gets approved for commercial use. More importantly, there is a large degree of uncertainty around approvals of Flaskworks. Forget about timing in terms of whether that takes 12, 18 or 24 months from now. They haven’t reported any successful validation runs. It will be another year after that before we get approval. And what if validation run doesn't go according to plan?
Most people value opportunity cost!
Market Data 
Markets 
AI
